- Endoscope
- Blood Test
- Others
Gastrointestinal Molecular Diagnostics Market size was valued at USD 4.3 billion in 2023, and is poised to grow at a CAGR of 3.6% from 2024 to 2030. The gastrointestinal molecular diagnostics market is anticipated to witness significant growth in the coming years, driven by several factors, such as the rising prevalence of gastrointestinal diseases, technological advancement (next-generation sequencing and PCR), growing awareness of the benefits of molecular diagnostics, and additionally supportive government policies around the world are creating a fertile ground for the global gastrointestinal molecular diagnostics market to flourish. Which empowers doctors to pinpoint and characterize genetic mutations linked to gastrointestinal diseases with exceptional precision and sensitivity. This, coupled with the growing need for early diagnoses and personalized treatments, which driving the gastrointestinal molecular diagnostics market demand in the fight against gastrointestinal ailments.
Gastrointestinal Molecular Diagnostics Market Key Developments:
- In June 2022, the SENTiFIT 800 analyzer, an automated system for Fecal Immunochemical tests, was launched by Sentinel Diagnostics.
- In March 2022, the agreement between Hardy Diagnostic and Applied BioCode for the distribution of the MDx-3000 System for the diagnosis of gastrointestinal infections.
Gastrointestinal Molecular Diagnostics Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
3.6%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Gastrointestinal Molecular Diagnostics Market Dynamics
The gastrointestinal molecular diagnostics market is expected to continue its growth trajectory in the coming years, driven by the increasing burden of gastrointestinal diseases according to the University of Gothenburg, in every ten adults in the world, four suffer from GIDs of varying severity, technological advancements in molecular biology techniques, such as next-generation sequencing (NGS) are leading to the development of more specific and sensitive diagnostic tests, and a growing emphasis on personalized medicine. However, addressing challenges related to cost and regulatory hurdles will be crucial for sustained market expansion.
North-America Got Significant Share of
Gastrointestinal Molecular Diagnostics Market Regional Analysis
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. The Asia-Pacific is the fastest growing due to the untapped market and increased cost-effective diagnosis solutions. In addition, the large pool of patients with a rising geriatric population in the region, and the increase in R&D activities related to gastrointestinal diseases will fuel segment growth. North America is a dominating market for gastrointestinal (GI) disorders and is expected to grow significantly due to several factors. These include the high prevalence of GI issues, rising public awareness of these conditions, and the well-established healthcare infrastructure in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The gastrointestinal molecular diagnostics market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
Gastrointestinal Molecular Diagnostics Market Segmentation
By Test Type
By Technology
- Polymer Chain Reaction
- Next-Generation Sequencing
- In Situ Hybridization (ISH)
- Microarrays
By Disease Indication
- Virus
Norovirus
Adenovirus
Rotavirus
Sapovirus - Bacteria
Difficle
Salmonella
Shigella - Parasite
Cryptosporidium
Entamoeba histolytica
Giardia Lamblia - Others
By Application
- Infectious Diseases
- Gastrointestinal Cancers
- Personalized Medicine
By End User
- Hospital & Clinics
- Research Institution
- Diagnostic Laboratories
Frequently Asked Questions
The gastrointestinal molecular diagnostics market is valued at USD 4.3 billion in 2023, and is poised to grow at a (CAGR) of 3.6% from 2024 to 2030.
F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation (Cepheid), Hologic, bioMérieux SA, Illumina, Inc., QIAGEN, BD, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Illumina, Inc.., Grifols, S.A., Siemens Healthineers AG, and Sysmex Corporation.
Asia-Pacific is the fastest growing and North America is the dominant market in Gastrointestinal molecular diagnostics
| 1.Executive Summary |
| 2.Global Gastrointestinal Molecular Diagnostics Market Introduction |
| 2.1.Global Gastrointestinal Molecular Diagnostics Market - Taxonomy |
| 2.2.Global Gastrointestinal Molecular Diagnostics Market - Definitions |
| 2.2.1.Test Type |
| 2.2.2.Technology |
| 2.2.3.Disease Indication |
| 2.2.4.Region |
| 3.Global Gastrointestinal Molecular Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Gastrointestinal Molecular Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Gastrointestinal Molecular Diagnostics Market By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Endoscope |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Blood Test |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Others |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Gastrointestinal Molecular Diagnostics Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Polymer Chain Reaction |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Next-Generation Sequencing |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. In Situ Hybridization (ISH) |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Microarrays |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Gastrointestinal Molecular Diagnostics Market By Disease Indication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Virus |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Bacteria |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Parasite |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Gastrointestinal Molecular Diagnostics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Gastrointestinal Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Endoscope |
| 9.1.2.Blood Test |
| 9.1.3.Others |
| 9.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Polymer Chain Reaction |
| 9.2.2.Next-Generation Sequencing |
| 9.2.3.In Situ Hybridization (ISH) |
| 9.2.4.Microarrays |
| 9.3. Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Virus |
| 9.3.2.Bacteria |
| 9.3.3.Parasite |
| 9.3.4.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Gastrointestinal Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Endoscope |
| 10.1.2.Blood Test |
| 10.1.3.Others |
| 10.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Polymer Chain Reaction |
| 10.2.2.Next-Generation Sequencing |
| 10.2.3.In Situ Hybridization (ISH) |
| 10.2.4.Microarrays |
| 10.3. Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Virus |
| 10.3.2.Bacteria |
| 10.3.3.Parasite |
| 10.3.4.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Gastrointestinal Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Endoscope |
| 11.1.2.Blood Test |
| 11.1.3.Others |
| 11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Polymer Chain Reaction |
| 11.2.2.Next-Generation Sequencing |
| 11.2.3.In Situ Hybridization (ISH) |
| 11.2.4.Microarrays |
| 11.3. Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Virus |
| 11.3.2.Bacteria |
| 11.3.3.Parasite |
| 11.3.4.Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Gastrointestinal Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Endoscope |
| 12.1.2.Blood Test |
| 12.1.3.Others |
| 12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Polymer Chain Reaction |
| 12.2.2.Next-Generation Sequencing |
| 12.2.3.In Situ Hybridization (ISH) |
| 12.2.4.Microarrays |
| 12.3. Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Virus |
| 12.3.2.Bacteria |
| 12.3.3.Parasite |
| 12.3.4.Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Gastrointestinal Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Endoscope |
| 13.1.2.Blood Test |
| 13.1.3.Others |
| 13.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Polymer Chain Reaction |
| 13.2.2.Next-Generation Sequencing |
| 13.2.3.In Situ Hybridization (ISH) |
| 13.2.4.Microarrays |
| 13.3. Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Virus |
| 13.3.2.Bacteria |
| 13.3.3.Parasite |
| 13.3.4.Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Hoffmann-La Roche AG |
| 14.2.2.Abbott Laboratories |
| 14.2.3.Danaher Corporation (Cepheid) |
| 14.2.4.Hologic, Inc. |
| 14.2.5.bioMérieux SA |
| 14.2.6.Illumina, Inc. |
| 14.2.7.QIAGEN |
| 14.2.8.BD |
| 14.2.9.Bio-Rad Laboratories, Inc. |
| 14.2.10.Agilent Technologies, Inc. |
| 14.2.11.Illumina, Inc. |
| 14.2.12.Grifols, S.A. |
| 14.2.13.Siemens Healthineers AG |
| 14.2.14.Sysmex Corporation |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Hoffmann-La Roche AG
- Abbott Laboratories
- Danaher Corporation (Cepheid)
- Hologic, Inc.
- bioMérieux SA
- Illumina, Inc.
- QIAGEN
- BD
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Grifols, S.A.
- Siemens Healthineers AG
- Sysmex Corporation